As a scientist, are you always focused on improving your metrics by such means as getting papers into prestigious journals? Do your funders and institutions add to that pressure to get ahead? If so, you may be at risk of a new psychiatric condition known as “Publiphilia Impactfactorius” — or, simply, PI, described in a PeerJ preprint. We talked to first author Joeri Tijdink at VU Medical Center (VUmc) in Amsterdam about this tongue-in-cheek take-down of the scientific condition, and whether there is any cure for the affliction.
Retraction Watch: You describe several new personality traits and clusters. Tell us more about this.
Historians, economists, biochemists, psychologists: Who reuses their own material most often? Does the rate depend on how many authors a paper has, and how far along a researcher is in his or her career?Serge Horbach andWillem Halffman at Radboud University Nijmegen in the Netherlands tried to answer these questions by reviewing more than 900 papers published by researchers based in The Netherlands. And they were surprised by their findings, published last month by Research Policy.
Retraction Watch: How does the amount of text recycling you identified among researchers at Dutch universities (6.1%) compare to what other studies have shown among other groups of researchers?
A social psychology journal has added an expression of concern to a paper by prominent social psychologist Jens Förster, whose work has been subject to much scrutiny.
This is the latest in a long-running saga involving Förster. The 2012 paper in the Journal of Experimental Social Psychology had been flagged by a 2015 report describing an investigation into Förster’s work, which had concluded the paper likely contained unreliable data. Several other papers that received similar designations in that report have either been retracted or received expressions of concern (EoC).
The (paywalled) notice provides a lengthy explanation for why the journal chose to add an EoC, rather than retract the paper, as the University of Amsterdam had recommended. Here is an excerpt:
In a letter, Ad Kaptein, a researcher at the Leiden University Medical Centre, in the Netherlands, wrote to say that a review and meta-analysis published by the journal that month hadn’t adequately cited the relevant literature in the field, including seven studies co-authored by Kaptein himself. The authors of the original paper say they had considered citing Kaptein’s work but decided against it, for various reasons.
The journal considered Kaptein’s complaint valid enough to publish his letter. But the letter carries the title “Expression of concern” — a term usually reserved for editorial notices issued by the journal to warn readers about some aspects of an article. But in this case, the author supplied the term, not the journal — yet the letter is tagged as an Expression of Concern on PubMed, giving the impression the paper has received a formal editorial notice.
Brachycephaly describes a condition where the back of the head is abnormally flat and trichomegaly refers to extra length, curling, pigmentation, or thickness of the eyelashes.
Marc Pieterse, of the Netherlands, has a son with the rare RPS23 mutation, one of two known patients in the world. The mutation affects ribosomes, cell components involved in protein production. On Aug. 9, we reported on Pieterse’s crusade against OMIM’s original name for the condition, which dubbed it a syndrome. He has feared that calling it a syndrome would “stigmatize” his son’s condition and tried to get the paper underpinning the OMIM entry retracted. The American Journal of Human Genetics has said it will not retract the paper.
The father of a boy with a rare genetic mutation has accused a scientist of exploiting his child by proclaiming the defect a “genetic syndrome” and naming it after herself.
At an impasse with scientists investigating, publicizing, and interpreting his son’s condition, the father seems willing to use any leverage he can muster to remove the “syndrome” entry in an online genetic disease database. Based solely on an email he obtained from the database director, the father became convinced that if the paper underpinning the entry were retracted, the syndrome would go down with it. So earlier this year, he withdrew his consent and asked the journal that published the paper for a retraction, based on improper patient consent. He has also threatened to lob accusations of research misconduct at the paper’s last author. Continue reading Fearing “stigmatization,” patient’s father seeks retraction of paper on rare genetic mutation